NCT06678620: Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine |
|
|
| Recruiting | 2 | 992 | RoW | Reinovax PCV24 formulation 1, Reinovax PCV24 formulation 2, Reinovax PCV24 formulation 3, PPSV23 | Shanghai Reinovax Biologics Co.,LTD | Pneumococcal Infectious Disease | 03/25 | 03/25 | | |